Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2012
At a glance
- Drugs Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jul 2012 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov record.
- 16 Oct 2005 New trial record.